Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia

Launched by CASE COMPREHENSIVE CANCER CENTER · Feb 12, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on collecting blood samples from adults who have a condition called thrombocytopenia, which means they have very low platelet counts. Platelets are important for helping your blood to clot, and having low levels can lead to issues like easy bruising or bleeding. The goal of this study is to gather information about patients with platelet counts of 30,000 per microliter or less, which can happen due to certain cancers or treatments.

To participate, you need to be at least 18 years old and meet the platelet count criteria. However, if you’ve received chemotherapy in the past 24 hours, used blood-thinning medications in the last 48 hours, or have an active infection, you won’t be eligible. Participants will simply provide one blood sample for research purposes, and the trial is currently looking for volunteers. This study is important because it aims to improve our understanding of thrombocytopenia in patients with blood-related cancers, which can help in developing better treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults 18 years or older
• • 2. Platelet counts of 30,000/mcl or less
• Exclusion Criteria:
• • 1. Chemotherapy within the last 24 hours from the planned blood sample draw for research purposes.
• • 2. Use of anticoagulant agents in the last 48 hours.
• • 3. Active infection (i.e. one that has received less than 48 hours of active treatment).
• • 4. Adults 89 years or older